The DOI matches its Crossref record; 95 of the 97 references it cites were found in a registry or an index; 29 of the 59 sources its claims cite were checked for support.
Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations
Open accessAbstract
AbstractMitochondria are organelles that govern energy supply and control cell death. Mitochondria also express bacterial features, such as the presence of inner membrane cardiolipin and a circular genome rich in hypomethylated CpG motifs. While mitochondrial extrusion by damaged organs or activated cells is thought to trigger innate immunity, it is unclear whether extracellular mitochondria also stimulate an adaptive immune response. We describe the development of novel assays to detect autoantibodies specific to two distinct components of the mitochondrion: the mitochondrial outer membrane and mitochondrial DNA. Antibodies to these two mitochondrial constituents were increased in both human and murine systemic lupus erythematosus (SLE), compared to controls, and were present at higher levels than in patients with antiphospholipid syndrome or primary biliary cirrhosis. In both bi- and multi-variate regression models, antibodies to mitochondrial DNA, but not whole mitochondria, were associated with increased anti-dsDNA antibodies and lupus nephritis. This study describes new and optimized methods for the assessment of anti-mitochondrial antibodies, and demonstrates their presence in both human and murine SLE. These findings suggest that different mitochondrial components are immunogenic in SLE, and support the concept that extracellular mitochondria may provide an important source of circulating autoantigens in SLE.
Overview
CoChat Summary
TL;DR
This study developed ELISAs for autoantibodies against whole mitochondria (AwMA) and mitochondrial DNA (AmtDNA) and found both elevated in human and murine SLE. AmtDNA, but not AwMA, was associated with increased anti-dsDNA antibodies and lupus nephritis.
Key findings
- AwMA and AmtDNA were increased in human SLE (n = 175) versus healthy controls (n = 43); AmtDNA was not increased in APS (n = 12) or PBC (n = 12), while AwMA was also elevated in APS/PBC but at lower levels than in SLE. Both antibody types were also elevated in a murine SLE model (SLE n = 12, control n = 8).
- AmtDNA was associated with increased anti-dsDNA antibodies (OR 3.34, 95% CI 1.22–9.16, p = 0.02) and lupus nephritis (OR 4.45, 95% CI 1.50–13.20, p = 0.007); both associations remained significant in multivariate models (p = 0.01 for both). AwMA was not associated with clinical outcomes.
- AwMA correlated with AmtDNA in SLE patients (rs = 0.23, p = 0.003) but not healthy controls (rs = 0.15, p = 0.33), and AwMA did not correlate with anti-HSP60 or anti-cardiolipin.
- Assay performance: AwMA sensitivity 0.58, specificity 0.88, AUC 0.80; AmtDNA sensitivity 0.63, specificity 0.74, AUC 0.71. Using cutoffs, 101/175 (57.71%) SLE patients were AwMA-positive and 110/175 (62.86%) were AmtDNA-positive.
Methods
- Mitochondria were isolated from mouse liver or Hep-G2 cells and purified by Percoll gradient; mtDNA was extracted by alkaline lysis. Direct ELISAs were developed using intact mitochondria as coating antigen for AwMA and protamine-sulfate-pre-coated plates with mtDNA for AmtDNA.
- Human sera included 175 SLE patients, 43 healthy controls, 12 APS patients, and 12 PBC patients; murine SLE was induced in C57BL/6J mice by β2GPI/LPS immunizations. Clinical data included anti-dsDNA by Farr assay and anti-cardiolipin by ELISA.
- Associations were assessed with Spearman correlations, Wilcoxon/Kruskal-Wallis/ANOVA tests, and bivariate/multivariate logistic regression; cutoffs were determined by Youden’s index with bootstrap confidence intervals.
Limitations
- Stated in the paper: findings require confirmation in an independent cohort and a larger lupus population over time; AwMA may also recognize other membrane-bound microparticles or cells; the role of oxidation on mtDNA recognition could not be tested because isolated mtDNA spontaneously oxidizes; the study focused on IgG only; whether AwMA are pathogenic initiators or consequences remains unknown; and the mitochondrial antigen(s) recognized in the AwMA assay are unidentified.
- Evident from the text: the human SLE cohort was cross-sectional and all female (Table 2), which limits causal/temporal inference and may affect generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
12 Valid · 2 Not valid · 13 Not checked · 84 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Various cellular lineages are capable of extruding their mitochondria. Activated mast cells10, T-cells11, eosinophils12, hepatocytes13, neutrophils14–16 and platelets17,18, in addition to damaged organs or tissues7,13,19,20, release extracellular mitochondria.”
§ Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations > Introduction
What the sources say
- Supportedcites [10] Zhang, B., Asadi, S., Weng, Z., Sismanopoulos, N. & Theoharides, T. C. Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One 7, e49767, https://doi.org/10.1371/journal.pone.0049767 (2012). source
The Results section, “Mast cell degranulation leads to extracellular mitochondrial particles secretion,” reports functional mitochondrial particles outside stimulated human mast cells while cell viability remained above 99%. Citation 10 is attached to activated mast cells; the other cell types and damaged tissues have separate citations. (LLM, conf=0.93)
- Partly supportedcites [11] Maeda, A. & Fadeel, B. Mitochondria released by cells undergoing TNF-alpha-induced necroptosis act as danger signals. Cell Death Dis. 5, e1312, https://doi.org/10.1038/cddis.2014.277 (2014). sourceExperimental — accuracy not yet measured
The Discussion and Results report extracellular release of intact mitochondria from cells undergoing TNF-α-induced necroptosis. This supports release from damaged or dying cells, but the study used in vitro cell models; it does not establish release from damaged organs or tissues, the part of the citing sentence to which this citation is attached. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [14] Yousefi, S., Mihalache, C., Kozlowski, E., Schmid, I. & Simon, H. U. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ. 16, 1438–1444, https://doi.org/10.1038/cdd.2009.96 (2009). source
- Partly supportedcites [15] Lood, C. et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22, 146–153, https://doi.org/10.1038/nm.4027 (2016). sourceExperimental — accuracy not yet measured
The citation to this paper is attached to neutrophils, not the other cell types or damaged tissues in the sentence. In Results (‘RNP ICs induce oxidized mtDNA release’; page unavailable), the paper reports that activated neutrophils mobilize mitochondria to the cell surface and release oxidized mitochondrial DNA in NETs. It does not establish that they release intact extracellular mitochondria. (LLM, conf=0.86)
- Disputedcites [16] Caielli, S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med. 213, 697–713, https://doi.org/10.1084/jem.20151876 (2016). sourceExperimental — accuracy not yet measured
For the neutrophil portion of the citing sentence, the Results section says that neutrophils release mtDNA–protein complexes, but the absence of outer mitochondrial membrane proteins suggests they do not extrude full mitochondria. The cited paper therefore makes a contrary distinction to the claim that neutrophils release extracellular mitochondria. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies showed that anti-mtDNA antibodies (AmtDNA) are induced in a subset of SLE patients, suggesting that extruded mtDNA could be a relevant source of antigen for the anti-double stranded DNA (anti-dsDNA) antibodies that prevail in SLE16,41,42.”
§ Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations > Introduction
What the sources say
- Partly supportedcites [16] Caielli, S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med. 213, 697–713, https://doi.org/10.1084/jem.20151876 (2016). sourceExperimental — accuracy not yet measured
The Results (Fig. 7; page not supplied) report anti–oxidized mtDNA autoantibodies in a fraction of SLE sera and identify oxidized mtDNA as an SLE autoantigen. The paper also reports neutrophil extrusion of mtDNA, but it does not establish that extruded mtDNA is an antigen for the broader anti-dsDNA antibodies referred to in the claim. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [41] Wang, H., Li, T., Chen, S., Gu, Y. & Ye, S. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Arthritis & rheumatology 67, 3190–3200, https://doi.org/10.1002/art.39296 (2015). source
- Not checked — no full text of the sourcecites [42] Reimer, G., Rubin, R. L., Kotzin, B. L., Tan, E. M. & Anti-native, D. N. A. antibodies from autoimmune sera also bind to DNA in mitochondria. J. Immunol. 133, 2532–2536 (1984). source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Studies showed that anti-mtDNA antibodies (AmtDNA) are induced in a subset of SLE patients, suggesting that extruded mtDNA could be a relevant source of antigen for the anti-double stranded DNA (anti-dsDNA) antibodies that prevail in SLE16,41,42.”
§ Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations > Introduction
What the sources say
- Supportedcites [16] Caielli, S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med. 213, 697–713, https://doi.org/10.1084/jem.20151876 (2016). source
The Results section reports anti–oxidized mtDNA autoantibodies in a fraction of SLE sera, supporting the claim that a subset of patients has anti-mtDNA antibodies. The antibodies measured were specifically against oxidized mtDNA. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [41] Wang, H., Li, T., Chen, S., Gu, Y. & Ye, S. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Arthritis & rheumatology 67, 3190–3200, https://doi.org/10.1002/art.39296 (2015). source
- Not checked — no full text of the sourcecites [42] Reimer, G., Rubin, R. L., Kotzin, B. L., Tan, E. M. & Anti-native, D. N. A. antibodies from autoimmune sera also bind to DNA in mitochondria. J. Immunol. 133, 2532–2536 (1984). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“the intravenous injection of mtDNA into mice failed to induce proteinuria and kidney damage68”
§ Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations > Discussion
What the sources say
- Supportedcites [68] He, J. et al. Circulating Mitochondrial DAMPs Are Not Effective Inducers of Proteinuria and Kidney Injury in Rodents. PLoS One 10, e0124469, https://doi.org/10.1371/journal.pone.0124469 (2015). source
The Results section (“Characterization of the mice treated with mitochondrial DAMPs”; page not provided) reports that injected mtDNA caused no high-level albuminuria and no kidney morphological abnormalities. It notes subtle increases in urinary albumin, but says these were too low to count as albuminuria. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Both sources of mitochondria (human Hep-G2 cells and mouse liver) were similarly recognized by human AwMA (Fig. 3b), suggesting that antigenic epitopes may be conserved across these species.”
§ Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
62 more claims
Create a free account to see all 111 claims and every source verdict.
- Probably not a substantial claim. 30
- It may state two separate claims as one. 16
- The quote only partly states this claim. 4
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nine of these anti-mitochondrial antibodies (AMA-M1 to AMA-M9) have been identified and named according to their specific characteristics (that is, the targets, pathological context of detection, appearance by indirect immunofluorescence (IIF), band labelling by western blot and ability to bind to complement)229–231.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Immunoreactivity to intact mitochondria (owing to the presence of anti-whole mitochondria antibodies) is increased in the sera of patients with SLE compared with that of healthy individuals and is associated with increased disease activity230,261,262.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antibodies to mitochondrial nucleic acids (mtDNA and mtRNA) are also present in patients with SLE or APS230,231,261,262.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IgG antibodies that target mtDNA (anti-mtDNA antibodies) are increased in the sera of patients with SLE compared with healthy individuals and are associated with disease activity and the development of lupus nephritis230.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [230]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With these methods, we isolated pure mitochondrial organelles, and we con fi rmed that both mtRNA and mtDNA preparations originate speci fi cally from mitochondria [6,7,8].”
From Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality (2026) · cites this paper as [7]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Neurologic disorder (seizure or psychosis) | 24 (12.0) |”
§ Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations > Results
Reported 12 · recomputed 13.714286
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812
The Role of Mitochondria in Apoptosis
Wang, C., & Youle, R. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134850 · Cited by 1,987
Mitochondrial form and function
Friedman, J. R., & Nunnari, J. (2014) · Nature · doi:10.1038/nature12985 · Cited by 1,803
Gray, M. W., Burger, G., & Lang, B. F. (1999) · Science · doi:10.1126/science.283.5407.1476 · Cited by 1,719
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584
Lood, C., Blanco, L. P., Purmalek, M. M., Carmona-Rivera, C., De Ravin, S. S., Smith, C. K., Malech, H. L., Ledbetter, J. A., Elkon, K. B., & Kaplan, M. J. (2016) · Nature Medicine · doi:10.1038/nm.4027 · Cited by 1,570
Cited by
Mitochondrial DNA in inflammation and immunity
Riley, J. S., & Tait, S. W. (2020) · EMBO reports · doi:10.15252/embr.201949799 · Cited by 865
“Successive work showed that NETs were also enriched for mtDNA [154 – 156].”
Platelet Extracellular Vesicles: Beyond the Blood
Puhm, F., Boilard, E., & Machlus, K. R. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.314644 · Cited by 250
Self-citationEmerging Role of Mitochondrial DNA as a Major Driver of Inflammation and Disease Progression
Zhong, F., Liang, S., & Zhong, Z. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.10.008 · Cited by 138
Platelets release mitochondrial antigens in systemic lupus erythematosus
Melki, I., Allaeys, I., Tessandier, N., Lévesque, T., Cloutier, N., Laroche, A., Vernoux, N., Becker, Y., Benk-Fortin, H., Zufferey, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aav5928 · Cited by 125
Self-citationQiu, C. C., Caricchio, R., & Gallucci, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02608 · Cited by 108
“The endogenous DNA, such as mitochondrial DNA (11, 105), can act as DAMP and be recognized by autoreactive B cells.”
Background
Metadata
- Authors
- Becker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., Eder, L., Wagner, É., Pelletier, M., Hajj, H. E., Tremblay, M.-È., Belleannée, C., Hébert, M.-J., Dieudé, M., Rauch, J., Fortin, P. R., & Boilard, E.
- Affiliations
- Centre de recherche du CHU de Québec-Université Laval (CA)
- Université Laval (CA)
- University of Toronto (CA)
- Centre hospitalier universitaire de Québec (CA)
- McGill University Health Centre (CA)
- Corresponding author
- Fortin, Paul R.
- ORCID
- Venue
- Scientific Reports
- Published
- 2019-03-14
- Volume
- 9
- Issue
- 1
- Pages
- 4530-4530
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC6418244
- OpenAlex
- W2921439506
- Semantic Scholar
- eeca2435cca8305a0be1d3cb6edd12f9b162f080
- Cited by
- 75
- References
- 97
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 10 · 2023: 11 · 2022: 13 · 2021: 7 · 2020: 8 · 2019: 4
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- McGill University
- Australian Government
- Canadian Blood Services
- Arthritis Society (225638)
- Canadian Institutes of Health Research (PJT159652)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, mitochondrial outer membrane, lupus nephritis, anti-dsDNA antibodies, extracellular mitochondria, autoantigens, cardiolipin, CpG motifs, murine lupus model, antiphospholipid syndrome, primary biliary cirrhosis
- MeSH terms
- Adult, Aged, Animals, Antibodies, Antinuclear, Autoantibodies, Disease Models, Animal, DNA, Mitochondrial, Female, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Mitochondria, Odds Ratio, Mitochondrial Proteins, Mice, Young Adult, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations. https://app.cochat.ai/papers/10.1038/s41598-019-40900-3
- The paper
- Becker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., Eder, L., Wagner, É., Pelletier, M., Hajj, H. E., Tremblay, M.-È., Belleannée, C., Hébert, M.-J., Dieudé, M., Rauch, J., . . . Boilard, E. (2019). Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations. Scientific Reports. https://doi.org/10.1038/s41598-019-40900-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.